Margaret Dugan
CIK 1909734 · Chief Medical Officer · last filed 2026-09-18
Margaret Dugan is a Chief Medical Officer who has filed 20 SEC Form 4 insider transactions across 4 companies since 2022. The most recent filing, for WHWK, was dated Sep 18, 2026. Across all open-market trades the lifetime net is −$122.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $30.0M across reported positions. 9 SEC filings were submitted jointly with BeiGene, Ltd. 3 Form 144 notices of planned sales are also on file; the latest, for BeOne Medicines Ltd. on May 22, 2026, lists the filer as a director.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ONC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
94 SOLARIS AVE, CAMANA BAY, PO BOX 1348
GRAND CAYMAN, E9 KY1-1108
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WHWK | Chief Medical Officer | 19,132 | $3.13 | $59.9K | $0 | 5 | 2026-09-18 |
| ONC | Director | 73,164 | $400.21 | $29.28M | -$65.6K | 3 | 2026-06-15 |
| SDGR | Chief Medical Officer | 24,574 | $26.64 | $654.7K | -$56.6K | 5 | 2025-10-17 |
| BeOne Medicines Ltd. (BGNE) Delisted | Director | 45,955 | $184.71 | $8.49M | $0 | 4 | 2024-06-07 |
10b5-1 Trading Plans
1 plan · 1 in force| Company | Adopted | Sales Can Start | Ends | Plan Allows | Sold So Far | Status | Link |
|---|---|---|---|---|---|---|---|
| SDGR Chief Medical Officer |
Nov 13, 2023 | Mar 1, 2024 | — | — | 2,926 last filed Oct 17, 2025 |
Active | 10-K |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-18 | WHWK | Grant (A) | — | $0 | EDGAR |
| 2026-09-15 | WHWK | Grant (A) | — | $0 | EDGAR |
| 2026-06-15 | ONC | Grant (A) | +18,980 | $0 | EDGAR |
| 2026-05-27 | ONC | Sell (S) | −212 | -$65.6K | EDGAR |
| 2026-05-22 | BeOne Medicines Ltd. | Notice (144) Director · Planned May 22, 2026 No sale on file |
−212 | -$65.6K | EDGAR |
| 2026-05-18 | WHWK | Grant (A) | +19,132 | $75.0K | EDGAR |
| 2026-04-03 | WHWK | Grant (A) | — | $0 | EDGAR |
| 2025-12-02 | WHWK | Grant (A) | — | $0 | EDGAR |
| 2025-10-17 | SDGR | Sell (S)10b5-1 Plan adopted Nov 13, 2023 |
−1,395 | -$29.4K | EDGAR |
| 2025-10-16 | SDGR | Notice (144) Officer · Planned Oct 16, 2025 Sold: Form 4 filed Oct 17, 2025 |
−1,395 | -$29.4K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).